Open access
Aug 2026
Tisa-cel and axi-cel CAR structure influences the development of resistance to CD19-CAR-T therapy.
It is shown that CAR structure is a critical determinant of CD19 loss in tumor B cells, and Mathematical modeling indicates that the failure of CD19-4-1BB-based CAR-T cells to eliminate CD19low cells, unlike CD28-based CARs, promotes the expansion of resistant populations.
Marta Krawczyk, K. Fidyt, Narcís Fernandez-Fuentes et al.
· Leukemia · 0 citations